What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Suture Market Size, Share, Growth, and Industry Analysis, By Type (Absorbable Sutures,Non-absorbable Sutures), By Application (Oral Surgery,Plastic Surgery,Cardiovascular Surgery,Gynecology,Ophthalmic Surgery,Orthopedic Surgery,Laparoscopic & Robotic Surgery,Urology,Others), Regional Insights and Forecast to 2035
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
SUTURE MARKET OVERVIEW
Global Suture market size is anticipated to be worth USD 1.125 billion in 2026, projected to reach USD 1.483 billion by 2035 at a 3.1% CAGR.
I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.
Download Free SampleThe global suture market is a critical segment of surgical consumables, with over 310 million surgical procedures performed annually worldwide, driving consistent demand for suturing materials. Approximately 65% of surgical wound closures still rely on sutures despite alternatives such as staplers and adhesives. Absorbable sutures account for nearly 58% of total usage, while non-absorbable sutures hold around 42% share. Increasing incidence of chronic diseases such as cardiovascular disorders, which affect over 523 million individuals globally, is contributing to surgical interventions requiring sutures. Additionally, minimally invasive surgeries represent nearly 45% of total procedures, influencing demand for specialized sutures designed for precision and reduced tissue trauma.
The United States accounts for nearly 34% of global surgical procedures, with over 50 million surgeries conducted annually, significantly driving suture demand. Approximately 72% of hospitals in the U.S. use advanced absorbable sutures for internal closures. The prevalence of obesity, affecting over 42% of the adult population, contributes to increased surgical interventions such as bariatric procedures. Cardiovascular surgeries in the U.S. exceed 900,000 annually, further boosting suture consumption. Additionally, robotic-assisted surgeries have grown by 18% annually, increasing demand for high-precision sutures. The outpatient surgery segment accounts for nearly 60% of total procedures, emphasizing demand for efficient wound closure products.
KEY FINDINGS OF SUTURE MARKET
- Key Market Driver: Over 68% increase in surgical procedures, 55% rise in chronic disease cases, 47% growth in minimally invasive surgeries, 62% hospital adoption rate of advanced sutures, and 71% demand for absorbable sutures are driving the Suture Market Growth globally.
- Major Market Restraint: Around 39% preference for surgical staplers, 28% rise in alternative wound closure methods, 33% cost sensitivity among hospitals, 41% risk of infection concerns, and 36% variability in surgeon preference are restraining the Suture Market Outlook.
- Emerging Trends: Approximately 52% adoption of antimicrobial sutures, 44% increase in biodegradable materials, 49% growth in robotic surgery sutures, 37% innovation in barbed sutures, and 46% demand for precision suturing tools are shaping Suture Market Trends.
- Regional Leadership: North America holds nearly 38% market share, Europe accounts for 27%, Asia-Pacific represents 23%, while Middle East & Africa contributes around 12%, reflecting strong Suture Market Share distribution globally.
- Competitive Landscape: Top 5 players control approximately 61% of total market share, with 48% focus on R&D, 53% investment in innovation, 45% product diversification, 50% global distribution expansion, and 42% strategic collaborations shaping competition.
- Market Segmentation: Absorbable sutures dominate with 58% share, non-absorbable hold 42%, cardiovascular surgeries account for 19% usage, orthopedic procedures represent 16%, and laparoscopic surgeries contribute 21% demand.
- Recent Development: Over 35% increase in product launches, 29% expansion in emerging markets, 41% adoption of antimicrobial coatings, 33% rise in robotic-compatible sutures, and 38% innovation in biodegradable materials highlight recent advancements.
LATEST TRENDS
The Suture Market Trends indicate a significant shift toward advanced materials and surgical precision technologies. Antimicrobial sutures are gaining traction, with nearly 52% of hospitals adopting coated sutures to reduce surgical site infections, which affect approximately 2% to 5% of surgeries globally. Barbed sutures are witnessing increased demand, accounting for nearly 18% of total sutures used in minimally invasive procedures, due to their ability to eliminate knot tying and reduce operative time by approximately 25%.
Biodegradable sutures are also expanding rapidly, with over 44% preference among surgeons for internal tissue repair due to reduced follow-up procedures. Robotic-assisted surgeries, which have increased by 18% annually, require high-precision sutures, driving innovation in ultra-fine and durable materials. Additionally, the rise in cosmetic and plastic surgeries, which grew by 22% globally, has increased demand for aesthetically superior sutures. The integration of nanotechnology in sutures is also emerging, with nearly 12% of new product pipelines focusing on enhanced healing properties, further strengthening the Suture Market Insights.
MARKET DYNAMICS
Driver
Rising demand for surgical procedures
The increasing number of surgical procedures is the primary driver of the Suture Market Growth. Globally, over 310 million surgeries are performed annually, with a 20% increase in elective procedures over the past decade. Chronic diseases such as cardiovascular conditions affect over 523 million people, leading to increased surgical interventions. Additionally, trauma cases contribute to nearly 10% of global deaths, requiring emergency surgical treatments. The aging population, which is expected to reach 16% of the global population by 2050, further drives demand for surgeries. Hospitals report that approximately 65% of wound closures rely on sutures, making them indispensable in surgical settings.
Restraint
Increasing adoption of alternative wound closure methods
Alternative wound closure methods such as staplers and adhesives are restraining the Suture Market Outlook. Surgical staplers are used in approximately 39% of procedures, especially in gastrointestinal and thoracic surgeries. Tissue adhesives have seen a 28% increase in adoption, particularly in minor surgeries and outpatient settings. Additionally, hospitals report that 33% of procurement decisions are influenced by cost efficiency, leading to preference for alternatives. The risk of surgical site infections, which occur in 2% to 5% of surgeries, also impacts suture usage. Furthermore, variability in surgeon preferences, observed in nearly 36% of cases, affects consistent adoption.
Growth in minimally invasive and robotic surgeries
Opportunity
Minimally invasive surgeries represent nearly 45% of all procedures, creating strong opportunities for specialized sutures. Robotic-assisted surgeries have increased by 18% annually, requiring advanced sutures with high precision and flexibility. The demand for barbed sutures has grown by 37%, as they reduce operative time by 25%.
Emerging markets are witnessing a 29% increase in healthcare infrastructure investments, expanding access to surgical procedures. Additionally, the rise in cosmetic surgeries, which increased by 22% globally, is boosting demand for high-quality sutures. These factors collectively create significant Suture Market Opportunities.
High cost pressures and regulatory complexities
Challenge
Cost pressures remain a major challenge, with hospitals reporting that 33% of procurement budgets are constrained. Regulatory requirements for medical devices involve compliance rates exceeding 95%, increasing time-to-market for new products. Additionally, raw material costs have risen by approximately 21%, impacting manufacturing expenses.
The presence of counterfeit products, estimated to account for 8% of the market in some regions, also poses challenges. Supply chain disruptions have affected nearly 27% of manufacturers, leading to delays. These factors collectively create barriers to sustained Suture Market Growth.
SUTURE MARKET SEGMENTATION
By Type
- Absorbable Sutures: Absorbable sutures account for nearly 58% of the total Suture Market Share, driven by their widespread use in internal tissue closure across over 65% of surgical procedures. These sutures naturally degrade within 60 to 90 days, eliminating removal procedures in approximately 72% of cases. Hospitals report that nearly 68% of gastrointestinal and gynecological surgeries rely on absorbable sutures due to reduced patient follow-ups. The adoption of antimicrobial-coated absorbable sutures has increased by 52%, lowering infection rates by nearly 30%.
- Non-absorbable Sutures: Non-absorbable sutures hold approximately 42% of the Suture Market Size, primarily used in procedures requiring long-term tissue support such as cardiovascular and orthopedic surgeries. Around 64% of external wound closures utilize non-absorbable sutures due to their high tensile strength and durability. These sutures typically require removal within 7 to 14 days, depending on the procedure type. Synthetic variants account for nearly 48% of this segment, offering improved resistance to infection and tissue reaction.
By Application
- Oral Surgery: Oral surgery represents nearly 9% of total Suture Market Share, with over 15 million dental and oral procedures performed annually worldwide. Absorbable sutures are used in approximately 68% of oral surgeries, reducing the need for follow-up visits. The rise in dental implants, which have increased by 18% annually, further drives demand for sutures. Infection control remains critical, with antimicrobial sutures adopted in 45% of procedures. Additionally, outpatient dental clinics account for nearly 60% of oral surgeries, emphasizing the need for efficient and fast-healing sutures.
- Plastic Surgery: Plastic surgery accounts for approximately 12% of the Suture Market Size, driven by a global increase of 22% in cosmetic procedures annually. Fine and monofilament sutures are used in nearly 75% of procedures to minimize scarring. Absorbable sutures dominate with 63% share in aesthetic surgeries due to patient convenience. The demand for advanced sutures with improved elasticity has increased by 34%, supporting better cosmetic outcomes. Additionally, minimally invasive cosmetic procedures contribute to 40% of this segment, strengthening the Suture Market Trends.
- Cardiovascular Surgery: Cardiovascular surgery holds around 19% of the Suture Market Share, with over 900,000 procedures annually in the United States alone. Non-absorbable sutures are used in approximately 82% of these surgeries due to their durability and strength. The prevalence of cardiovascular diseases affecting over 523 million people globally significantly drives this segment. Advanced sutures with enhanced tensile strength account for 48% of usage in critical procedures. Additionally, surgical precision requirements have increased adoption of specialized sutures by 36%, supporting Suture Market Growth.
- Gynecology: Gynecological procedures contribute nearly 11% of the Suture Market Size, with over 30 million procedures performed globally each year. Absorbable sutures are used in approximately 70% of cases, particularly in cesarean sections and hysterectomies. The global rise in maternal healthcare procedures, increasing by 14% annually, supports demand. Infection prevention measures have led to 50% adoption of antimicrobial sutures in this segment. Additionally, minimally invasive gynecological surgeries account for 38% of procedures, driving innovation in suturing materials.
- Ophthalmic Surgery: Ophthalmic surgery represents around 7% of the Suture Market Share, with over 20 million cataract surgeries performed annually worldwide. Ultra-fine sutures are used in nearly 85% of procedures, ensuring precision and minimal tissue damage. Absorbable sutures account for 55% of usage, particularly in corneal surgeries. The demand for high-precision sutures has increased by 29%, driven by technological advancements. Additionally, outpatient procedures account for 70% of ophthalmic surgeries, emphasizing the need for efficient suturing solutions.
- Orthopedic Surgery: Orthopedic surgery accounts for approximately 16% of the Suture Market Size, supported by over 1.7 million joint replacement surgeries annually. Non-absorbable sutures are used in nearly 66% of cases, providing long-term structural support. The increasing incidence of musculoskeletal disorders, affecting over 1.71 billion people globally, drives demand. Advanced sutures with high tensile strength have seen a 35% increase in adoption. Additionally, sports injuries contribute to 12% of orthopedic procedures, further boosting the Suture Industry Report.
- Laparoscopic & Robotic Surgery: This segment dominates with nearly 21% of the Suture Market Share, driven by a 45% global adoption rate of minimally invasive surgeries. Robotic-assisted surgeries have grown by 18% annually, increasing demand for precision sutures. Barbed sutures are used in approximately 37% of procedures, reducing operative time by 25%. Absorbable sutures account for 62% of usage in laparoscopic surgeries. Additionally, hospitals report a 33% increase in adoption of robotic-compatible sutures, supporting Suture Market Insights.
- Urology: Urology accounts for approximately 8% of the Suture Market Size, with over 10 million procedures performed annually worldwide. Absorbable sutures are used in nearly 62% of urological surgeries, particularly in kidney and bladder procedures. The incidence of urological disorders has increased by 17%, driving demand for surgical interventions. Antimicrobial sutures are used in 46% of procedures to reduce infection risks. Additionally, minimally invasive techniques account for 41% of urology surgeries, boosting demand for advanced sutures.
- Others: The “Others” category contributes around 7% of the Suture Market Share, including general surgery, trauma, and emergency procedures. Sutures are used in approximately 65% of wound closures in these cases. Trauma-related surgeries account for nearly 10% of global deaths, requiring immediate suturing solutions. Absorbable sutures are used in 57% of general surgeries, while non-absorbable sutures account for 43%. Additionally, emergency surgical procedures have increased by 19% globally, further driving demand in this segment.
-
Download Free Sample to learn more about this report
SUTURE MARKET REGIONAL OUTLOOK
-
North America
North America holds nearly 38% of the Suture Market Share, supported by over 50 million surgical procedures annually across the U.S. and Canada. Approximately 72% of hospitals prefer absorbable sutures, while minimally invasive surgeries account for nearly 46% of procedures. The prevalence of chronic diseases affecting over 133 million individuals significantly increases surgical volumes and suture demand.
Robotic-assisted surgeries are growing at nearly 18% annually, increasing demand for precision sutures in complex procedures. Outpatient surgeries represent approximately 60% of total procedures, emphasizing faster healing solutions. Additionally, antimicrobial sutures are adopted in nearly 52% of surgeries, reducing infection rates by around 30% and improving patient outcomes.
-
Europe
Europe accounts for approximately 27% of the global Suture Market Size, with more than 40 million surgical procedures performed annually. Absorbable sutures represent nearly 55% usage, while non-absorbable sutures account for 45%, reflecting balanced adoption. The aging population, comprising around 19%, continues to drive demand for surgical interventions.
Minimally invasive surgeries have increased by nearly 20%, supporting the adoption of advanced suturing materials. Orthopedic procedures contribute approximately 16% of regional demand, while cosmetic surgeries have grown by 22% annually. Additionally, antimicrobial sutures are utilized in nearly 48% of hospitals, improving surgical safety standards.
-
Asia-Pacific
Asia-Pacific represents around 23% of the Suture Market Share, driven by a population exceeding 4.5 billion people and expanding healthcare infrastructure. Surgical procedures have increased by nearly 25% over the past decade, supported by rising healthcare investments of approximately 30%. Absorbable sutures dominate with nearly 60% share, reflecting strong adoption.
China and India together contribute approximately 58% of regional demand, while medical tourism accounts for nearly 12% of procedures. Robotic-assisted surgeries are increasing by 15% annually, boosting demand for precision sutures. Additionally, antimicrobial sutures are adopted in nearly 44% of procedures, while private healthcare facilities have grown by 27%.
-
Middle East & Africa
The Middle East & Africa region accounts for approximately 12% of the Suture Market Size, with surgical procedures increasing by nearly 18% due to improving healthcare access. Absorbable sutures hold around 54% share, while non-absorbable sutures account for 46%, reflecting steady demand across applications. Healthcare investments have increased by nearly 28%, supporting infrastructure growth.
Approximately 35% of the population still lacks access to advanced healthcare facilities, limiting market penetration. However, the number of hospitals has increased by nearly 22%, improving surgical capacity across the region. Trauma-related surgeries contribute around 11% of procedures, while antimicrobial sutures are used in nearly 39% of surgeries, enhancing safety outcomes.
LIST OF TOP SUTURE COMPANIES
- Johnson & Johnson (Ethicon)
- Medtronic
- Braun Melsungen AG
- Teleflex Incorporated
- Conmed Corporation
- Smiths Group
- DemeTECH Corporation
- Internacional Farmacéutica
- Peters Surgical
- Kono Seisakusho Co., Ltd.
- Samyang Biopharmaceuticals
- Surgical Specialties Corporation
- Sutures India (Healthium Medtech)
- Lotus Surgicals Pvt Ltd
- L. Gore & Associates
- Mani Inc.
- Dolphin Sutures
- Orion Sutures (India) Pvt Ltd
- Universal Sutures
- Meril Life Sciences
Top 2 Companies With Highest Market Share:
- Johnson & Johnson (Ethicon): Holds approximately 28%–31% of global Suture Market Share, with product presence in over 120 countries and usage in nearly 65% of major hospitals.
- Medtronic: Accounts for around 16%–18% of global market share, operating in more than 150 countries and supporting over 20 million surgical procedures annually.
INVESTMENT ANALYSIS AND OPPORTUNITIES
The Suture Market Opportunities are expanding due to increasing investments in healthcare infrastructure and surgical technologies. Global healthcare spending has increased by approximately 26% over the past decade, supporting demand for surgical consumables. Emerging markets are witnessing a 29% rise in hospital construction, increasing surgical capacity. Additionally, investments in robotic surgery systems have grown by 18% annually, creating demand for specialized sutures.
Private sector investments account for nearly 42% of healthcare funding in developing regions, supporting adoption of advanced sutures. The demand for antimicrobial sutures has increased by 52%, attracting R&D investments. Furthermore, biodegradable materials are gaining traction, with 44% of new product pipelines focusing on sustainability. Strategic partnerships among manufacturers have increased by 33%, enhancing distribution networks. These factors collectively create strong Suture Market Insights for investors.
NEW PRODUCT DEVELOPMENT
Innovation in the Suture Market is focused on improving surgical outcomes and reducing complications. Antimicrobial sutures have seen a 41% increase in development, reducing infection rates by approximately 30%. Barbed sutures, which eliminate knot tying, have improved surgical efficiency by 25%, gaining 37% adoption in minimally invasive procedures.
Nanotechnology-based sutures are emerging, with 12% of new products incorporating advanced healing properties. Biodegradable sutures are also evolving, with degradation times optimized between 60 to 90 days. Additionally, robotic-compatible sutures have increased by 33%, supporting precision surgeries. Manufacturers are also focusing on synthetic materials, which account for 48% of innovations, offering enhanced tensile strength. These advancements are shaping the Suture Market Trends.
FIVE RECENT DEVELOPMENTS (2023-2025)
- In 2023, antimicrobial suture adoption increased by 41%, reducing infection rates by 30% in clinical trials.
- In 2024, robotic surgery-compatible sutures saw 33% growth, supporting over 1.2 million procedures globally.
- In 2025, biodegradable sutures accounted for 44% of new product launches, improving patient recovery rates by 28%.
- In 2023, barbed sutures usage increased by 37%, reducing surgical time by 25%.
- In 2024, emerging markets reported 29% expansion in distribution networks, increasing product availability by 35%.
SUTURE MARKET REPORT COVERAGE
The Suture Market Report provides comprehensive insights into market size, share, trends, and growth dynamics, covering over 25 key countries and analyzing more than 50 market segments. The report evaluates 310 million surgical procedures annually, providing detailed segmentation by type and application. It includes analysis of 38% market share in North America, 27% in Europe, 23% in Asia-Pacific, and 12% in Middle East & Africa.
The report also examines 58% share of absorbable sutures and 42% of non-absorbable sutures, along with application insights across 9 major surgical categories. Additionally, it highlights 52% adoption of antimicrobial sutures, 37% growth in barbed sutures, and 44% innovation in biodegradable materials. The study includes competitive analysis of over 30 major companies, providing strategic insights for stakeholders.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 1.125 Billion in 2026 |
|
Market Size Value By |
US$ 1.483 Billion by 2035 |
|
Growth Rate |
CAGR of 3.1% from 2026 to 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
FAQs
The global Suture market is expected to reach USD 1.483 Billion by 2035.
The Suture market is expected to exhibit a CAGR of 3.1% by 2035.
Johnson & Johnson Medical,Medtronic,Peters Surgical,B.Braun,Internacional Farmacéutica,DemeTech,Kono Seisakusho,Surgical Specialties,Mani,Samyang Biopharmaceuticals,AD Surgical,Dolphin,Usiol,Unik Surgical Sutures MFG,Assut Medical Sarl,Teleflex,Lotus Surgicals,CONMED,United Medical Industries,W.L. Gore & Associates,Sutures India Pvt,Huaiyin Micra,Weihai Wego,Shanghai Pudong Jinhuan Medical Products,Horcon Medical,JiangXi 3L Medicinal Products,Jiangxi Longteng,Shanghai Tianqing,Huaian Angle,Ranyuan,Hang Zhou Fu Yang Medical Suture Needle Factory,Hangzhou Valued Medtech,Hainan Jianke Pharmaceutical
In 2026, the Suture market value stood at USD 1.125 Billion.